Clinicopathological significance of intestinal metaplasia in endoscopically resected early gastric carcinoma
Journal of Digestive Diseases · 2023
DOI: 10.1111/1751-2980.13245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2023. Verfasst von Yu Qing Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Top Talent of Changzhou "The 14th Five-Year Plan" High-level Health Talents Training Project of the Health Commission of the Changzhou City, Changzhou Science & Technology Program.
Abstract (Originalsprache)
Objective
To investigate the clinicopathological and prognostic significance of intestinal metaplasia (IM) in endoscopically resected early gastric carcinoma (EGC).
Methods
Altogether 136 consecutive cases with EGC resected by endoscopic submucosal dissection over 5 years were included and divided into the early gastric cardiac (EGCC; n = 60) and non‐cardiac carcinoma (EGNCC; n = 76) groups. Goblet cell IM and subtypes were determined with histology and immunostaining. Recurrence‐free survival (RFS) was compared among various IM groups.
Results
IM was identified in 128 (94.1%) EGC cases, including complete IM (n = 39), incomplete IM (n = 27), and mixed IM (n = 62). Incomplete IM was significantly more common in EGCC and exhibited a lower frequency of en bloc resection than the complete subtype. The frequency of synchronous or metachronous gastric tumor was significantly more common in EGCC with complete IM than in those with incomplete IM. Compared to EGC without IM, EGC with IM showed a significantly higher frequency of non‐poorly cohesive carcinoma, en bloc resection, and non‐eCuraC‐1 grade. EGNCC with IM was significantly associated with negative resection margins and en bloc resection. The 5‐year RFS was significantly lower in EGNCC patients with incomplete IM compared with those with mixed IM. The independent risk factors for RFS included tumor size >2 cm and eCuraC‐1 grade.
Conclusions
Subtyping IM in EGC helped predict endoscopic resectability, prognosis, and risk of synchronous or metachronous gastric tumor. The significance of IM differed between EGCC and EGNCC. Large studies with longer follow‐up are warranted to validate our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
- Graduate School of Dalian Medical University, Dalian, Liaoning Province, China.
- Department of Gastroenterology, Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
- Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Yu Qing Cheng
Förderung
- Top Talent of Changzhou "The 14th Five-Year Plan" High-level Health Talents Training Project of the Health Commission of the Changzhou City
- Changzhou Science & Technology Program
Zitieren
APA
Cheng, Y. Q., Zhang, X. W., Zhuang, S. H., Zhou, X. L., & Huang, Q. (2023). Clinicopathological significance of intestinal metaplasia in endoscopically resected early gastric carcinoma. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13245
Vancouver
Cheng YQ, Zhang XW, Zhuang SH, Zhou XL, Huang Q. Clinicopathological significance of intestinal metaplasia in endoscopically resected early gastric carcinoma. Journal of Digestive Diseases. 2023. doi:10.1111/1751-2980.13245
BibTeX
@article{Cheng2023,
author = {Cheng, Yu Qing and Zhang, Xin Wen and Zhuang, Shao Hua and Zhou, Xiao Li and Huang, Qin},
title = {Clinicopathological significance of intestinal metaplasia in endoscopically resected early gastric carcinoma},
journal = {Journal of Digestive Diseases},
year = {2023},
doi = {10.1111/1751-2980.13245}
}
EUVIMED